The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users
Abstract
CONTEXT: In British Columbia, human immunodeficiency virus (HIV)-infected persons eligible for antiretroviral therapy may receive it free but the extent to which HIV-infected injection drug users access it is unknown. OBJECTIVE: To identify patient and physician characteristics associated with antiretroviral therapy utilization in HIV-infected injection drug users. DESIGN: Prospective cohort study with record linkage between survey data and data from a provincial HIV/AIDS (acquired immunodeficiency syndrome) drug treatment program. SETTING: British Columbia, where antiretroviral therapies are offered free to all persons with HIV infection with CD4 cell counts less than 0.50 x 10(9)/L (500/microL) and/or HIV-1 RNA levels higher than 5000 copies/mL. SUBJECTS: A total of 177 HIV-infected injection drug users eligible for antiretroviral therapy, recruited through the prospective cohort study since May 1996. MAIN OUTCOME MEASURES: Patient use of antiretroviral drugs through the provincial drug treatment program and physician experience treating HIV infection. RESULTS: After a median of 11 months after first eligibility, only 71 (40%) of 177 patients had received any antiretroviral drugs, primarily double combinations (47/71 [66%]). Both patient and physician characteristics were associated with use of antiretroviral drugs. After adjusting for CD4 cell count and HIV-1 RNA level at eligibility, odds of not receiving antiretrovirals were increased more than 2-fold for females (odds ratio [OR], 2.53; 95% confidence interval [CI], 1.08-5.93) and 3-fold for those not currently enrolled in drug or alcohol treatment programs (OR, 3.49; 95% CI, 1.45-8.40). Younger drug users were less likely to receive therapy (OR, 0.47/10-y increase; 95% CI, 0.28-0.80). Those with physicians having the least experience treating persons with HIV infection were more than 5 times less likely to receive therapy (OR, 5.55; 95% CI, 2.49-12.37). CONCLUSIONS: Despite free antiretroviral therapy, many HIV-infected injection drug users are not receiving it. Public health efforts should target younger and female drug users, and physicians with less experience treating HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,640
A case-control study of HIV seroconversion in health care workers after percutaneous exposure.
Cardo, D. M., Culver, D. H., Ciesielski, C. A., Srivastava, P. U., Marcus, R., Abiteboul, D., Heptonstall, J., Ippolito, G., Lot, F., McKibben, P. S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372101 · Cited by 1,198
Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., et al. (1998) · JAMA · doi:10.1001/jama.280.1.78 · Cited by 995
Carpenter, C. C. J. (1997) · JAMA · doi:10.1001/jama.1997.03540480062040 · Cited by 725
Physicians' Experience with the Acquired Immunodeficiency Syndrome as a Factor in Patients' Survival
Kitahata, M. M., Koepsell, T. D., Deyo, R. A., Maxwell, C. L., Dodge, W. T., & Wagner, E. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341106 · Cited by 456
A CASE-CONTROL STUDY OF HIV SEROCONVERSION IN HEALTH CARE WORKERS AFTER PERCUTANEOUS EXPOSURE
Ardo, M. C., Ulver, D. A. H. C., Iesielski, C. A. A. C., Amela, P., Arcus, R. U. M., Biteboul, D. O. A., Eptonstall, J. U. H., L, F. L., Ibben, P. E. S. M. C. K., & Ell, D. A. M. B. (1997) · Cited by 383
Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban Community
Moore, R. D., Stanton, D., Gopalan, R., & Chaisson, R. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403173301107 · Cited by 356
Self-reported Antiretroviral Therapy in Injection Drug Users
Celentano, D. D. (1998) · JAMA · doi:10.1001/jama.280.6.544 · Cited by 258
Effect of antiviral treatment on the shedding of HIV-1 in semen
Vernazza, P., Gilliam, B. L., Flepp, M., Dyer, J. R., Frank, A. C., Fiscus, S. A., Cohen, M. S., & Eron, J. J. (1997) · AIDS · doi:10.1097/00002030-199710000-00008 · Cited by 155
Protease Inhibitors in the Homeless
Bangsberg, D. R. (1997) · JAMA · doi:10.1001/jama.1997.03550010077044 · Cited by 150
Variation in Health Service Use Among HIV-lnfected Patients
Mor, V., Fleishman, J. A., Dresser, M., & Piette, J. D. (1992) · Medical Care · doi:10.1097/00005650-199201000-00002 · Cited by 145
Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons
Stein, M. D., Piette, J. D., Mor, V., Wachtel, T. J., Fleishman, J. A., Mayer, K. H., & Carpenter, C. C. J. (1991) · Journal of General Internal Medicine · doi:10.1007/bf02599388 · Cited by 137
Determinants of HIV seroconversion in drug users during a period of rising prevalence in Vancouver
Patrick, D. M., Strathdee, S. A., Archibald, C. P., Ofner, M., Craib, K. J. P., Cornelisse, P. G. A., Schechter, M. T., Rekart, M. L., & O'Shaughnessy, M. V. (1997) · International Journal of STD & AIDS · doi:10.1258/0956462971920497 · Cited by 119
Self-citationAccess to therapy in the multicenter AIDS Cohort Study, 1989–1992
Graham, N. M. H., Jacobson, L. P., Kuo, V., Chmiel, J. S., Morgenstern, H., & Zucconi, S. L. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90115-5 · Cited by 102
The use of health services by women with HIV infection.
Hellinger, F. J. (1993) · Europe PMC (PubMed Central) · Cited by 93
Human immunodeficiency virus infection in intravenous drug users: A model for primary care
O’Connor, P. G., Molde, S., Henry, S., et al. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90166-9 · Cited by 79
Implications of Generalists' Slow Adoption of Zidovudine in Clinical Practice
Markson, L. E. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130091012 · Cited by 69
Cited by
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., & Moss, A. (2000) · AIDS · doi:10.1097/00002030-200003100-00008 · Cited by 1,033
Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C., Buono, D., Eckholdt, H., Howard, A. A., & Schoenbaum, E. E. (2001) · Clinical Infectious Diseases · doi:10.1086/323201 · Cited by 637
(2002) · PubMed Central · Cited by 522
Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002) · Journal of General Internal Medicine · doi:10.1007/s11606-002-0044-3 · Cited by 501
Metadata
- Authors
- Strathdee, S. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1998-08-12
- Volume
- 280
- Issue
- 6
- Pages
- 547
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2021847155
- Cited by
- 505
- References
- 18
- FWCI
- 20.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.